PDB30 EVALUATING THE COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 VERSUS HUMAN PREMIX INSULIN FOR THE TREATMENT OFTYPE 2 DIABETES IN A SPANISH SETTING
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)64978-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)64978-9/fulltext
Title :
PDB30 EVALUATING THE COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 VERSUS HUMAN PREMIX INSULIN FOR THE TREATMENT OFTYPE 2 DIABETES IN A SPANISH SETTING
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64978-9&doi=10.1016/S1098-3015(10)64978-9
First page :
Section Title :
Open access? :
No
Section Order :
137